Product
IBC0966
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of IBC0966 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-12-01